Brief: N4 Pharma Filed New Patent For Its IBD Product In Early Pre-Clinical Development
Dec 4 - N4 Pharma PLC N4P.L :
* N4 PHARMA PLC - FILED NEW PATENT FOR ITS IBD PRODUCT IN
EARLY
PRE-CLINICAL DEVELOPMENT
(( Reuters.Briefs@thomsonreuters.com))
Recent news on Thalia Therapeutics
See all newsThalia Therapeutics - Interim Results
Brief: Thalia Therapeutics Says New Patent Granted For Miristen In China
Thalia Therapeutics - New Patent Granted for miRisten in China
Thalia Therapeutics - RNA gene-silencing cardiovascular program advances
Thalia Therapeutics - Business Update and Notice of Results